ArticleFrontiers in immunology2025

Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study.

Liying Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.